Added to YB: 2026-08-17
Pitch date: 2026-08-13
GMED [bullish]
Globus Medical, Inc.
+1.37%
current return
Author Info
Aurelion Research is a research analyst with a passion for markets, specializing in high‑conviction ideas across shipping, offshore drilling, and thematic equity research. Sign up for the newsletter.
Company Info
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Market Cap
$11.5B
Pitch Price
$84.74
Price Target
112.00 (+30%)
Dividend
N/A
EV/EBITDA
10.41
P/E
21.97
EV/Sales
3.44
Sector
Health Care Equipment and Supplies
Category
value
New Position: Long-Term Compounder in Surgical Robotics
GMED (new position): Spine/ortho medtech at 11x EBITDA (17x normalized FCF), below peers & own history. Q2 base biz +9%, US Spine +7% (5th qtr above mkt). Margins expanding to 35%+ via in-housing NuVasive/Nevro (bought cheap, synergies early). ExcelsiusGPS robotics free optionality. YE26 PT $112, ~11% EPS CAGR, 8% organic growth. Risks: Medtronic/Stryker competition, Nevro turnaround, sales force retention.
Read full article (12 min)